Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apararenone (Low Dose) in Diabetic Nephropathy
NCT02205372Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jul 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apararenone in diabetic nephropathy (DN), sponsored by Mitsubishi Tanabe Pharma Corporation. Started Jul 2014; status: completed.
02
Drugs
apararenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02205372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205372.